Improving serrated adenoma detection rate in the colon by electronic chromoendoscopy and distal attachment: systematic review and meta-analysis.


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
11 2019
Historique:
received: 09 05 2019
accepted: 26 06 2019
pubmed: 10 7 2019
medline: 21 4 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

The evidence for modification of conventional colonoscopy using either "distal attachments" (DAs; endocap, endocuff, and endoring) or "electronic chromoendoscopy" (EC; narrow-band imaging [NBI], iScan, blue-light imaging, autofluorescence imaging, and linked-color imaging) to improve the detection of serrated adenomas during colonoscopy has shown conflicting results. A comprehensive literature search was performed using Medline, Google Scholar, Embase, and Cochrane Library based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Randomized controlled trials (RCTs) comparing any DA or EC with high-definition white-light colonoscopy for detection of serrated adenomas (sessile serrated adenoma/polyp and traditional serrated adenoma) were included. The primary outcome was serrated adenoma detection rate (SADR) defined as the number of patients with at least 1 serrated adenoma of total patients in that group. The secondary outcome was the number of serrated adenomas per subject. Pooled rates were reported using risk ratio (RR) with 95% confidence interval. Seventeen studies with 13,631 patients (56% men; age range, 50-66 years) met the inclusion criteria. The use of DAs (RR, 1.21; P = .45) and EC (RR, 1.29; P = .09) during colonoscopy did not show a significant improvement in SADR. The SADR using EC was 6.9% (4 studies) and that with NBI alone was 3.7% (3 studies). The results indicate that, except for NBI, the use of DAs or EC during colonoscopy does not improve detection of serrated adenomas in the colon. More RCTs evaluating NBI are needed to explore the effect.

Sections du résumé

BACKGROUND AND AIMS
The evidence for modification of conventional colonoscopy using either "distal attachments" (DAs; endocap, endocuff, and endoring) or "electronic chromoendoscopy" (EC; narrow-band imaging [NBI], iScan, blue-light imaging, autofluorescence imaging, and linked-color imaging) to improve the detection of serrated adenomas during colonoscopy has shown conflicting results.
METHODS
A comprehensive literature search was performed using Medline, Google Scholar, Embase, and Cochrane Library based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Randomized controlled trials (RCTs) comparing any DA or EC with high-definition white-light colonoscopy for detection of serrated adenomas (sessile serrated adenoma/polyp and traditional serrated adenoma) were included. The primary outcome was serrated adenoma detection rate (SADR) defined as the number of patients with at least 1 serrated adenoma of total patients in that group. The secondary outcome was the number of serrated adenomas per subject. Pooled rates were reported using risk ratio (RR) with 95% confidence interval.
RESULTS
Seventeen studies with 13,631 patients (56% men; age range, 50-66 years) met the inclusion criteria. The use of DAs (RR, 1.21; P = .45) and EC (RR, 1.29; P = .09) during colonoscopy did not show a significant improvement in SADR. The SADR using EC was 6.9% (4 studies) and that with NBI alone was 3.7% (3 studies).
CONCLUSIONS
The results indicate that, except for NBI, the use of DAs or EC during colonoscopy does not improve detection of serrated adenomas in the colon. More RCTs evaluating NBI are needed to explore the effect.

Identifiants

pubmed: 31288029
pii: S0016-5107(19)32045-0
doi: 10.1016/j.gie.2019.06.041
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

721-731.e1

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Muhammad Aziz (M)

Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Madhav Desai (M)

Department of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA; Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Seemeen Hassan (S)

Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.

Rawish Fatima (R)

Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Chandra S Dasari (CS)

Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Viveksandeep Thoguluva Chandrasekar (VT)

Department of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA; Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Ramprasad Jegadeesan (R)

Department of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA; Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Abhiram Duvvuri (A)

Department of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA; Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Harsh Patel (H)

Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Tarun Rai (T)

Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Anjana Sathyamurthy (A)

Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Divyanshoo R Kohli (DR)

Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Prashanth Vennalaganti (P)

Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Ali Nawras (A)

Department of Gastroenterology, University of Toledo Medical Center, Toledo, Ohio, USA.

Michael Wallace (M)

Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.

Prateek Sharma (P)

Department of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA; Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH